{
  "title": "Paper_181",
  "abstract": "pmc Int J Syst Evol Microbiol Int J Syst Evol Microbiol 1256 ijs ijsem International Journal of Systematic and Evolutionary Microbiology 1466-5026 1466-5034 Microbiology Society PMC12494484 PMC12494484.1 12494484 12494484 41042680 10.1099/ijsem.0.006931 006931 1 Research Article New Taxa Actinomycetota Umbribacter vaginalis gen. nov., sp. nov.: novel bacterium isolated from the human vagina https://orcid.org/0000-0002-7267-3859 Srinivasan Sujatha 1 * ssriniva@fredhutch.org Strenk Susan M. 1 sstrenk@fredhutch.org Beamer May A. 2 mbeamer@mwri.magee.edu Fiedler Tina L. 1 tfiedler@fredhutch.org Proll Sean 1 sproll@fredhutch.org Acevedo-Oquendo Gabriela R. 2 gabriela.acevedo7@upr.edu Bonura Gina M. 2 bonurag@upmc.edu Nagana Gowda G. A. 3 ngowda@uw.edu Raftery Daniel 3 4 draftery@uw.edu Hillier Sharon L. 2 5 3 hillsl@mwri.magee.edu Fredricks David N. 1 6 dfredric@fredhutch.org 1 Vaccine and Infectious Disease Division Fred Hutchinson Cancer Center Seattle WA USA 2 Magee-Womens Research Institute Pittsburgh PA USA 3 Northwest Metabolomics Research Center and Mitochondrial and Metabolism Center, Department of Anesthesiology and Pain Medicine University of Washington Medical Center Seattle WA USA 4 Public Health Sciences Division Fred Hutchinson Cancer Center Seattle WA USA 5 University of Pittsburgh School of Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences Pittsburgh PA USA 6 Department of Medicine University of Washington Seattle WA USA D.N.F. and T.L.F. have received a royalty from BD for molecular diagnosis of BV. S.L.H. has received research funding from Cepheid and consulting fees from Freya Biosciences. Sujatha Srinivasan, ssriniva@fredhutch.org Supplement: 2025 03 10 2025 75 10 498140 006931 08 5 2025 16 9 2025 03 10 2025 04 10 2025 04 10 2025 Copyright © 2025 The Authors 2025 https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License. Abstract Gram-variable obligately anaerobic novel bacteria DNF00809 and PR-HUZ-602407-17 were isolated from vaginal fluid samples from women with bacterial vaginosis (BV) in two independent studies conducted in different laboratories. They each displayed ≥99.9% 16S rRNA gene sequence identity to the uncultured bacterial clone sequence AY738656 Eggerthella T T T 14 : 0 16 : 0 16 : 0 18 : 1 cis T Eggerthellaceae Umbribacter vaginalis T T T bacterial vaginosis bacterial vaginosis (BV)-associated bacteria Eggerthellaceae genital tract human vagina http://dx.doi.org/10.13039/100015691 Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases UM1AI068633 L Hillier Sharon http://dx.doi.org/10.13039/100000051 National Human Genome Research Institute HG005816 N Fredricks David http://dx.doi.org/10.13039/100015691 Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases P30AI036219 Hillier Sharon L. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes Introduction Novel anaerobic vaginal bacterial strains DNF00809 and PR-HUZ-602407-17 isolated from human vaginal fluid samples in two separate studies showed ≥99.9% 16S rRNA gene sequence identity to the uncultured bacterial clone sequence AY738656 Eggerthella 1 1 5 6 5 7 in vivo 8 In addition to strong associations with BV, ELVB has been associated with a tenfold increased risk for developing subsequent pelvic inflammatory disease (PID) among individuals that tested positive for ELVB in the preceding 3 months of PID diagnosis [ 9 10 11 12 13 Although we have limited understanding of the mechanistic role of ELVB in BV and how they mediate PID or HIV risk, their clinical significance warrants systematic characterization and valid naming of this novel vaginal bacterium as it will enable reproducible research using a well-characterized type strain across laboratories. Here, we compare the ELVB isolate DNF00809 with validly named species within the Eggerthellaceae Umbribacter vaginalis T Isolation DNF00809 T 14 15 −7 Eggerthellaceae AY738656 −5 AY738656 16S rRNA gene sequence analysis The 16S rRNA gene sequences for DNF00809 T blast https://blast.ncbi.nlm.nih.gov/Blast.cgi 16 T AY738656 Eggerthella 1 T Eggerthellaceae Fig. 1 Eggerthellaceae clustalw 17 megax 18 T Adlercreutzia agrestimuris T Fig. 1 T A. agrestimuris Eggerthellaceae Eggerthellaceae Fig. 1. Molecular phylogenetic analysis by maximum composite likelihood method based on 16S rRNA gene sequences showing the phylogenetic positions of U. vaginalis T U. vaginalis Eggerthellaceae nt Olsenella profusa T AF292374 Lancefieldella parvula T NR_102936 Fannyhessea vaginae T ACGK00000000.2 Atopobiaceae Whole-genome phylogeny and analysis DNF00809 T 19 https://github.com/rrwick/Unicycler/releases 20 22 23 T CP189841 CP197404 T T A whole-genome phylogenetic tree ( Fig. 2 Eggerthellaceae https://www.bv-brc.org/ 24 Table 1 nt aa T Eggerthellaceae http://tygs.dsmz.de 25 27 https://www.ezbiocloud.net/tools/ani 28 29 https://enveomics.scigap.org/ Fig. 3 Fig. 2. Phylogenomic tree derived from concatenated 100 single-copy marker genes showing the relationship of U. vaginalis T U. vaginalis Eggerthellaceae nt Olsenella profusa T JAUSQK000000000 Lancefieldella parvula T CP001721 Fannyhessea vaginae T ADNA00000000 Atopobiaceae Fig. 3. Genome-based species delineation using the ( a blast U. vaginalis T U. vaginalis Adlercreutzia equolifaciens equolifaciens T 30 Cryptobacterium curtum T 31 Eggerthella lenta T 32 Gordonibacter pamelaeae T 33 Paraeggerthella hongkongensis T 33 34 Slackia exigua T 35 36 b c Table 1. Comparison of genome characteristics of U. vaginalis Eggerthellaceae Strains GenBank accession Genome length (Mb) No. of protein coding genes No. of tRNA genes No. of rRNA genes DNA G+C content (mol%) 1 CP189841 1.78 1,614 47 4 46.1 2 CP197404 1.68 1,488 47 4 46.3 3 AP013105.1 2.86 2,324 48 4 63.5 4 CP001682 1.62 1,351 47 6 50.9 5 CP001726 3.63 3,212 48 6 64.2 6 FP929047 3.61 3,083 47 2 60.4 7 QICD00000000 2.80 2,619 54 3 60.9 8 ACUX00000000 2.10 1,813 47 12 62.1 1, U. vaginalis U. vaginalis Adlercreutzia equolifaciens equolifaciens 30 Cryptobacterium curtum 31 Eggerthella lenta 32 Gordonibacter pamelaeae 33 Paraeggerthella hongkongensis 33 34 Slackia exigua 35 36 G+C data was obtained from the genome information provided by the BV-BRC 3.25.0 ( https://www.bv-brc.org/ 24 Representative validly named members of the Eggerthellaceae Adlercreutzia equolifaciens equolifaciens T 30 Cryptobacterium curtum T 31 Eggerthella lenta T 32 Gordonibacter pamelaeae T 33 Paraeggerthella hongkongensis T 33 34 Slackia exigua T 35 36 The phylogenomic tree of DNF00809 T Fig. 2 T T T Eggerthellaceae Fig. 3 37 38 Eggerthellaceae 37 39 T Eggerthellaceae Physiology and chemotaxonomy All bacterial strains were maintained anaerobically on BRU or Wilkins–Chalgren Anaerobe Broth (Thermo Fisher Scientific, Waltham, MA) with 3% sterile heat-inactivated fetal bovine serum (3% FBS-WC) (Corning, NY). An anaerobic atmosphere for all experiments was created using a trimix of 90% N 2 2 2 Optimal atmosphere was tested by growing the isolates in aerobic, microaerophilic and anaerobic conditions. DNF00809 T T T T Motility was assessed using 0.3% agar 3% FBS-WC plates with four replicates. Briefly, 2 ml of 3% FBS-WC broth culture for each isolate was centrifuged, and the pellets were resuspended in 200 µl 3% FBS-WC broth. The 0.3% agar plates were stabbed with a P10 pipette tip and then inoculated with the resuspension. The plates were incubated for a total of 10 days. Escherichia coli T Table 2 40 Paeniclostridium sordellii T E. coli T Table 2 Table 2. Comparison of defining characteristics for selected type strains within the Eggerthellaceae 1 2 3 4 5 6 7 8 % Similarity to Eggerthella AY738656 99.9 99.9 92.4 91.2 90.6 91.6 92.1 90.7  Defining characteristics: Aerotolerance OA OA OA OA OA OA OA OA Cell morphology C/CB C/CB CB R R CB CB R Cell length (µm) 1.08 1.09 1.5–2.7  nd 0.2–2.0 0.8–1.2  nd 1.0 Gram stain GV GV GP GP GP GP GP GP Motility − − − − − + − − Sporulation − − − − − − − −  Presence of: Catalase  w  nd  nd − − + − − Oxidase −  nd  nd  nd  nd  nd  nd  nd Nitrate reduction − − − − + − − −  Susceptibility to: Bile, 1 mg S  nd S  nd  nd  nd  nd S Colistin, 10 µg R  nd  nd  nd  nd  nd  nd  nd Vancomycin, 5 µg S  nd  nd  nd v  nd S  nd Kanamycin, 1000 µg S  nd  nd  nd  nd  nd  nd  nd Clindamycin, MIC, µg ml −1 0.06, S  nd  nd  nd  nd  nd  nd  nd Metronidazole, MIC, µg ml −1 0.5, S  nd  nd  nd S  nd 1, S  nd  Production of: Indole −  nd  nd −  nd  nd − − Acetic acid + + − − − − − − Formic acid + + − − − − − − Fumaric acid + + + − + + + − Isobutyric acid + + + + + + + − Lactic acid − − + + + + + + Malonic acid − − − − + + + − Phenylacetic acid + + + + + + + + Propionic acid + + + + + + + + Pyroglutamic acid + + + + + + + + Pyruvic acid + + − − − − − −  Reactions to API 32A substrates* Arginine arylamidase +  nd +  nd  nd − v + Phenylalanine arylamidase +  nd −  nd  nd − − + Leucine arylamidase +  nd +  nd  nd − v + Tyrosine arylamidase +  nd −  nd  nd − − + Glycine arylamidase +  nd −  nd  nd − − + Histidine arylamidase +  nd −  nd  nd − − + Serine arylamidase +  nd −  nd  nd − − +, W  Reactions to API ZYM substrates* Esterase (C4) +  nd  nd  nd  nd  nd  nd  nd Esterase lipase (C8) +  nd  nd  nd  nd  nd  nd  nd Leucine arylamidase +  nd  nd  nd  nd  nd  nd  nd Valine arylamidase +, W  nd  nd  nd  nd  nd  nd  nd Naphthol-AS-BI-phosphohydrolase +  nd  nd  nd  nd  nd  nd  nd 1, U. vaginalis U vaginalis A. equolifaciens equolifaciens 30 C. curtum 31 E. lenta 32 G. pamelaeae 33 P. hongkongensis 33 34 S. exigua 35 36 U. vaginalis *Only those that are positive for DNF00809T are shown here. C, cocci; CB, coccobacillus; GP, Gram-positive; GV, Gram variable; nd Colony and cellular morphologies were assessed using a dissecting microscope after DNF00809 T T T T et al 41 42 T Eggerthellaceae Table 2 43 T Fig. 4 T Fig. 4. Scanning electron micrographs (bar, 1 µm) of cells of ( a U. vaginalis T b U. vaginalis c U. vaginalis T d U. vaginalis All biochemical testing was performed in duplicate. Initial biochemical tests included catalase (3%, Thermo Fisher Scientific), oxidase (Becton Dickinson) and spot indole (prepared in-house) [ 42 T Table 2 T Table 2 T T Eggerthellaceae A. equolifaciens S. exigua 30 36 The cellular fatty acid composition of DNF00809 T Eggerthellaceae Table 2 T 44 T 14 : 0 16 : 0 16 : 0 18 : 1 cis Eggerthellaceae 16 : 0 16 : 0 18 : 1 cis Table 3 Table 3. Comparison of FAME analysis of novel strains with select organisms within the Eggerthellaceae Fatty acid composition 1 2 3 5 6 7 12 : 0 2.3 2.3 – – – – 14 : 0  10.2  7.9 – –  8.7 – 14 : 0 iso 0.6 0.8 2.8  5.6  6.8  5.1 14 : 0 DMA 1.3 1.1 – –  9.7 – 15 : 0 iso 1.4 2 – – – – 15 : 0 anteiso 2.3  5.5 – 4  19.8 4.2 15 : 0 iso DMA 0.4 0.6 – –  6.1 – 16 : 0  15.4  14.8  11.4  7.4 –  5.7 16 : 0 DMA  19.4  18.2  11.4  37.7  13.5  28.8 16 : 0 aldehyde 2.4 2.5 2.8  10.3 –  5.7 17 : 0 DMA 0.4 0.4 – – – 2.2 18 : 0 4.5 4.5  11.4  5.3 –  5.8 18 : 0 aldehyde 0.3 0.4 3.6 – – 2.4 18 : 0 DMA 1.5 1.4  18.5  5.3 –  14.1 18 : 1 ω  24.9  21.3  24.1  24.3 3.7  20.4 18 : 1 ω 2.4 1.5 – – – – 18 : 2 ω 1.4 1.9 – – – – 18 : 1 ω 2.3 3.6  7.8 – – – 18 : 1 ω 0.7 0.7 – – 1.5 2.9 Summed feature 10 – – 1.2 – – 2.8 1, U. vaginalis U vaginalis A. equolifaciens equolifaciens 30 E. lenta 32 G. pamelaeae 33 P. hongkongensis 33 34 U. vaginalis , C. curtum 31 , S. exigua 35 36 ω ω ω Metabolic end products were measured in both the Umbribacter 1 43 Eggerthellaceae Umbribacter Table 2 Fig. 5 Umbribacter Eggerthellaceae Table 2 Fig. 5 Fig. 5. Concentrations of short-chain fatty acids produced after growth of bacterial cells in 3% FBS-WC broth for 72 h at 37 °C. Results are reported as mean values of duplicate experiments, and the overall error is 6.2% between duplicate values. Data for Umbribacter , U. vaginalis T U vaginalis A. equolifaciens equolifaciens T 30 C. curtum T 31 E. lenta T 32 G. pamelaeae T 33 P. hongkongensis T 33 34 S. exigua T 35 36 Antimicrobial susceptibility was performed using the agar dilution method on BRU as per the Clinical and Laboratory Standards Institute (CLSI) for anaerobic bacteria [ 45 46 49 T Table 2 −1 −1 −1 −1 −1 −1 45 50 T T 42 T Table 2 Description of Umbribacter Umbribacter umbra bacter Umbribacter Cells stain Gram variable, are obligately anaerobic, non-motile, non-spore forming, asaccharolytic and proteolytic. Predominant cell wall fatty acid methyl esters include dimethyl acetals, monounsaturated fatty acids and saturated, unbranched fatty acids. The type species is U. vaginalis Description of Umbribacter vaginalis Umbribacter vaginalis vaginalis Colonies are punctiform, clear like a water droplet, flat and shiny with a diameter of 0.3–0.4 mm following 5 days anaerobic incubation at 37 °C on Brucella agar supplemented with 5% laked sheep blood, hemin and vitamin K. Growth is similar on Wilkins–Chalgren Anaerobe Agar with 3% sterile heat-inactivated fetal bovine serum with colonies appearing as punctiform, clear, flat and shiny after at least 5 days of anaerobic incubation. Once the colony size of 0.3–0.4 mm is achieved, additional incubation does not result in an increase in colony size. Cells are non-motile, non-spore forming, stain as Gram-variable cocci and coccobacilli and are ~1.08–1.09 µm in length and 0.44–0.52 µm in width. The bacterium is sensitive to vancomycin, kanamycin and bile, resistant to colistin, weakly positive for catalase activity and negative for oxidase activity and nitrate reduction and does not produce indole. Optimal temperature for growth ranges between 30 and 37 °C. Asaccharolytic, with enzymatic activities present for arginine arylamidase, phenylalanine arylamidase, leucine arylamidase, valine arylamidase, esterase, esterase lipase and naphthol-AS-BI-phosphohydrolase. Major metabolic end products produced are acetate, formate, fumarate, phenylacetate, propionate, pyruvate, pyroglutamate and succinate. Susceptible to clindamycin and metronidazole. Predominant cell wall fatty acids are C 14 : 0 16 : 0 16 : 0 18 : 1 cis The type strain is DNF00809 T T T KP192306 CP189841 Supplementary material 10.1099/ijsem.0.006931 Uncited Supplementary Material 1. Acknowledgements We thank DJ Valint for performing SEM, Steve MacFarlane from the Fred Hutch Electron Microscopy team for providing EM guidance and Samuel S. Minot for processing the sequencing data from bacterial isolates and assembling their genomes. Funding: Ethical statement: Abbreviations AAI average aa ANI average nt BV bacterial vaginosis BV-BRC Bacterial and Viral Bioinformatics Resource Center dDDH digital DNA–DNA hybridization ELVB Eggerthella FAME fatty acid methyl ester HIV human immunodeficiency virus PID pelvic inflammatory disease SEM scanning electron microscopy TEM transmission electron microscopy References 1. Fredricks DN Fiedler TL Marrazzo JM Molecular identification of bacteria associated with bacterial vaginosis N Engl J Med 2005 353 1899 1911 10.1056/NEJMoa043802 16267321 2. Datcu R Gesink D Mulvad G Montgomery-Andersen R Rink E et al Vaginal microbiome in women from Greenland assessed by microscopy and quantitative PCR BMC Infect Dis 2013 13 480 10.1186/1471-2334-13-480 24131550 PMC3853076 3. Ling Z Liu X Luo Y Wu X Yuan L et al Associations between vaginal pathogenic community and bacterial vaginosis in Chinese reproductive-age women PLoS One 2013 8 e76589 10.1371/journal.pone.0076589 24124575 PMC3790675 4. Shipitsyna E Roos A Datcu R Hallén A Fredlund H et al Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One 2013 8 e60670 10.1371/journal.pone.0060670 23585843 PMC3621988 5. Srinivasan S Hoffman NG Morgan MT Matsen FA Fiedler TL et al Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria PLoS One 2012 7 e37818 10.1371/journal.pone.0037818 22719852 PMC3377712 6. Fredricks DN Fiedler TL Thomas KK Oakley BB Marrazzo JM Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis J Clin Microbiol 2007 45 3270 3276 10.1128/JCM.01272-07 17687006 PMC2045326 7. Carter KA Balkus JE Anzala O Kimani J Hoffman NG et al Associations between vaginal bacteria and bacterial vaginosis signs and symptoms: a comparative study of Kenyan and American women Front Cell Infect Microbiol 2022 12 801770 10.3389/fcimb.2022.801770 35310847 PMC8931342 8. Valint DJ Fiedler TL Liu C Srinivasan S Fredricks DN Effect of metronidazole on concentrations of vaginal bacteria associated with risk of HIV acquisition mBio 2024 15 e0111024 10.1128/mbio.01110-24 39570045 PMC11633388 9. Haggerty CL Ness RB Totten PA Farooq F Tang G et al Presence and concentrations of select bacterial vaginosis-associated bacteria are associated with increased risk of pelvic inflammatory disease Sex Transm Dis 2020 47 344 346 10.1097/OLQ.0000000000001164 32149953 PMC7167351 10. McClelland RS Lingappa JR Srinivasan S Kinuthia J John-Stewart GC et al Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study Lancet Infect Dis 2018 18 554 564 10.1016/S1473-3099(18)30058-6 29396006 PMC6445552 11. Srinivasan S Richardson BA Wallis JM Fiedler TL Strenk SM et al Vaginal bacteria and proinflammatory host immune mediators as biomarkers of human immunodeficiency virus acquisition risk among African women J Infect Dis 2024 230 1444 1455 10.1093/infdis/jiae406 39248500 PMC11646615 12. Fredricks DN Plantinga A Srinivasan S Oot A Wiser A et al Extra-vaginal bacterial colonization and risk for incident bacterial vaginosis in a population of women who have sex with men J Infect Dis 2020 225 1261 1265 10.1093/infdis/jiaa233 PMC8974833 32379324 13. Yu B Liu C Proll SC Manhardt E Liang S et al Identification of fallopian tube microbiota and its association with ovarian cancer Elife 2024 12 RP89830 10.7554/eLife.89830 38451065 PMC10942644 14. Srinivasan S Munch MM Sizova MV Fiedler TL Kohler CM et al More easily cultivated than identified: classical isolation with molecular identification of vaginal bacteria J Infect Dis 2016 214 Suppl 1 S21 8 10.1093/infdis/jiw192 27449870 PMC4957512 15. Hanks JH Wallace RE Relation of oxygen and temperature in the preservation of tissues by refrigeration Proc Soc Exp Biol Med 1949 71 196 200 10.3181/00379727-71-17131 18134009 16. Altschul SF Gish W Miller W Myers EW Lipman DJ Basic local alignment search tool J Mol Biol 1990 215 403 410 10.1016/S0022-2836(05)80360-2 2231712 17. Tamura K Nei M Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees Mol Biol Evol 1993 10 512 526 10.1093/oxfordjournals.molbev.a040023 8336541 18. Kumar S Stecher G Li M Knyaz C Tamura K MEGA X: Molecular Evolutionary Genetics Analysis across computing platforms Mol Biol Evol 2018 35 1547 1549 10.1093/molbev/msy096 29722887 PMC5967553 19. Srinivasan S Austin MN Fiedler TL Strenk SM Agnew KJ et al Amygdalobacter indicium Amygdalobacter nucleatus Oscillospiraceae Int J Syst Evol Microbiol 2023 73 006017 10.1099/ijsem.0.006017 37787404 PMC11318147 20. Haft DH DiCuccio M Badretdin A Brover V Chetvernin V et al RefSeq: an update on prokaryotic genome annotation and curation Nucleic Acids Res 2018 46 D851 D860 10.1093/nar/gkx1068 29112715 PMC5753331 21. Li W O’Neill KR Haft DH DiCuccio M Chetvernin V et al RefSeq: expanding the prokaryotic genome annotation pipeline reach with protein family model curation Nucleic Acids Res 2021 49 D1020 D1028 10.1093/nar/gkaa1105 33270901 PMC7779008 22. Tatusova T DiCuccio M Badretdin A Chetvernin V Nawrocki EP et al NCBI prokaryotic genome annotation pipeline Nucleic Acids Res 2016 44 6614 6624 10.1093/nar/gkw569 27342282 PMC5001611 23. Parks DH Imelfort M Skennerton CT Hugenholtz P Tyson GW CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes Genome Res 2015 25 1043 1055 10.1101/gr.186072.114 25977477 PMC4484387 24. Wattam AR Davis JJ Assaf R Boisvert S Brettin T et al Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center Nucleic Acids Res 2017 45 D535 D542 10.1093/nar/gkw1017 27899627 PMC5210524 25. Meier-Kolthoff JP Auch AF Klenk HP Göker M Genome sequence-based species delimitation with confidence intervals and improved distance functions BMC Bioinformatics 2013 14 60 10.1186/1471-2105-14-60 23432962 PMC3665452 26. Meier-Kolthoff JP Hahnke RL Petersen J Scheuner C Michael V et al Complete genome sequence of DSM 30083(T), the type strain (U5/41(T)) of Escherichia coli Stand Genomic Sci 2014 9 2 10.1186/1944-3277-9-2 25780495 PMC4334874 27. Meier-Kolthoff JP Klenk H-P Göker M Taxonomic use of DNA G+C content and DNA-DNA hybridization in the genomic age Int J Syst Evol Microbiol 2014 64 352 356 10.1099/ijs.0.056994-0 24505073 28. Yoon S-H Ha S-M Kwon S Lim J Kim Y et al Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies Int J Syst Evol Microbiol 2017 67 1613 1617 10.1099/ijsem.0.001755 28005526 PMC5563544 29. Yoon SH Ha SM Lim J Kwon S Chun J A large-scale evaluation of algorithms to calculate average nucleotide identity Antonie Van Leeuwenhoek 2017 110 1281 1286 10.1007/s10482-017-0844-4 28204908 30. Maruo T Sakamoto M Ito C Toda T Benno Y Adlercreutzia equolifaciens Eggerthella Int J Syst Evol Microbiol 2008 58 1221 1227 10.1099/ijs.0.65404-0 18450717 31. Nakazawa F Poco SE Ikeda T Sato M Kalfas S et al Cryptobacterium curtum Int J Syst Bacteriol 1999 49 Pt 3 1193 1200 10.1099/00207713-49-3-1193 10425779 32. Kageyama A Benno Y Nakase T Phylogenetic evidence for the transfer of Eubacterium lentum Eggerthella Eggerthella lenta Int J Syst Evol Microbiol 1999 49 1725 1732 10.1099/00207713-49-4-1725 10555354 33. Würdemann D Tindall BJ Pukall R Lünsdorf H Strömpl C et al Gordonibacter pamelaeae Eggerthella hongkongensis Paraeggerthella hongkongensis Int J Syst Evol Microbiol 2009 59 1405 1415 10.1099/ijs.0.005900-0 19502325 34. Lau SKP Woo PCY Woo GKS Fung AMY Wong MKM et al Eggerthella hongkongensis Eggerthella sinensis Eggerthella Eggerthella Diagn Microbiol Infect Dis 2004 49 255 263 10.1016/j.diagmicrobio.2004.04.012 15313530 35. Poco SE Jr Nakazawa F Ikeda T Sato M Sato T et al Eubacterium exiguum Int J Syst Bacteriol 1996 46 1120 1124 10.1099/00207713-46-4-1120 8863445 36. Wade WG Downes J Dymock D Hiom SJ Weightman AJ et al The family Coriobacteriaceae: reclassification of Eubacterium Peptostreptococcus heliotrinreducens Slackia exigua Slackia heliotrinireducens Eubacterium Eggerthella lenta Int J Syst Bacteriol 1999 49 Pt 2 595 600 10.1099/00207713-49-2-595 10319481 37. Konstantinidis KT Tiedje JM Towards a genome-based taxonomy for prokaryotes J Bacteriol 2005 187 6258 6264 10.1128/JB.187.18.6258-6264.2005 16159757 PMC1236649 38. Konstantinidis KT Tiedje JM Genomic insights that advance the species definition for prokaryotes Proc Natl Acad Sci USA 2005 102 2567 2572 10.1073/pnas.0409727102 15701695 PMC549018 39. Riesco R Trujillo ME Update on the proposed minimal standards for the use of genome data for the taxonomy of prokaryotes Int J Syst Evol Microbiol 2024 74 006300 10.1099/ijsem.0.006300 38512750 PMC10963913 40. Koransky JR Allen SD Dowell VR Jr Use of ethanol for selective isolation of sporeforming microorganisms Appl Environ Microbiol 1978 35 762 765 10.1128/aem.35.4.762-765.1978 348108 PMC242919 41. Halebian S Harris B Finegold SM Rolfe RD Rapid method that aids in distinguishing Gram-positive from Gram-negative anaerobic bacteria J Clin Microbiol 1981 13 444 448 10.1128/jcm.13.3.444-448.1981 6165736 PMC273811 42. Summanen P Baron EJ Citron DM Strong CA Wexler H et al Wadsworth Anaerobic Bacteriology Manual, 5th edition Belmont, CA Star Publishing 1993 43. Srinivasan S Beamer MA Fiedler TL Austin MN Sizova MV et al Megasphaera lornae Megasphaera hutchinsoni Megasphaera vaginalis Int J Syst Evol Microbiol 2019 71 10.1099/ijsem.0.004702 PMC8161547 33616513 44. Sasser M Identification of Bacteria by Gas Chromatography of Cellular Fatty Acids (Technical Note No. 101) Newark, DE Microbial ID Inc 1990 45. Clinical Laboratory Standards Institute (CLSI) Methods for antimicrobial susceptibility testing of anaerobic bacteria, in CLSI Standard M11 Wayne PA Clinical and Laboratory Standards Institute: Wayne PA 2018 46. Hanson JM McGregor JA Hillier SL Eschenbach DA Kreutner AK et al Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy J Reprod Med 2000 45 889 896 11127100 47. Mitchell CM Assessment and treatment of vaginitis Obstet Gynecol 2024 144 765 781 10.1097/AOG.0000000000005673 38991218 48. Muzny CA Balkus J Mitchell C Sobel JD Workowski K et al Diagnosis and management of bacterial vaginosis: summary of evidence reviewed for the 2021 centers for disease control and prevention sexually transmitted infections treatment guidelines Clin Infect Dis 2022 74 S144 S151 10.1093/cid/ciac021 35416968 49. Paavonen J Mangioni C Martin MA Wajszczuk CP Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial Obstet Gynecol 2000 96 256 260 10.1016/s0029-7844(00)00902-9 10908773 50. Clinical Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing. in CLSI Standard M100 Clinical and Laboratory Standards Institute 2022 ",
  "metadata": {
    "Title of this paper": "Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial",
    "Journal it was published in:": "International Journal of Systematic and Evolutionary Microbiology",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494484/"
  }
}